GCH1 heterozygous mutation identified by whole-exome sequencing as a treatable condition in a patient presenting with progressive spastic paraplegia

J Neurol. 2014 Mar;261(3):622-4. doi: 10.1007/s00415-014-7265-3. Epub 2014 Feb 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Carbidopa / administration & dosage
  • Carbidopa / pharmacology*
  • Codon, Nonsense / genetics
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / pharmacology*
  • Drug Combinations
  • Dystonic Disorders / diagnosis*
  • Dystonic Disorders / drug therapy
  • Dystonic Disorders / genetics
  • Exome
  • Female
  • GTP Cyclohydrolase / genetics*
  • Heterozygote
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / pharmacology*
  • Phenotype
  • Sequence Analysis, DNA
  • Spastic Paraplegia, Hereditary / diagnosis*
  • Spastic Paraplegia, Hereditary / drug therapy
  • Spastic Paraplegia, Hereditary / genetics
  • Treatment Outcome

Substances

  • Codon, Nonsense
  • Dopamine Agonists
  • Drug Combinations
  • carbidopa, levodopa drug combination
  • Levodopa
  • GTP Cyclohydrolase
  • Carbidopa

Supplementary concepts

  • Dystonia, Dopa-responsive